Anagrelide and anaemia Patient Reports February 10, 2010

Anagrelide Side Effects Report #5715764-4
Anagrelide side effect was reported by a Physician from SWEDEN on Apr 08, 2008. Male patient, 68 years of age, was diagnosed with essential thrombocythaemia, myelofibrosis and was treated with Anagrelide. After drug was administered, patient experienced the following side effects: anaemia, myelofibrosis, platelet count increased, therapeutic response delayed, thrombocytopenia. Anagrelide dosage: 1.0 MG AM AND 2.0 MG EVENING, ORAL. During the same period patient was treated with PEGASYS. Patient recovered.

Anagrelide Side Effects Report #4758675-3
Anagrelide side effect was reported by a Physician from FRANCE on Aug 17, 2005. Male patient, 46 years of age, weighting 154.3 lb, was diagnosed with essential thrombocythaemia and was treated with Anagrelide. After drug was administered, patient experienced the following side effects: anaemia, coronary artery insufficiency, coronary artery thrombosis, platelet count increased. Anagrelide dosage: unknown. During the same period patient was treated with HYDREA, ACETYLSALICYLATE LYSINE. Patient was hospitalized. Patient recovered.

Anagrelide Side Effects Report #5031381-6
Anagrelide side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 22, 2005. Male patient was diagnosed with essential thrombocythaemia and was treated with Anagrelide. After drug was administered, patient experienced the following side effects: anaemia, pericarditis. Anagrelide dosage: 1 MG,2X/DAY:BID. Patient was hospitalized. Patient recovered.